Address
Email address
Phone number
https://chemi-pharm.comChemi-Pharm | Allergen-Free Disinfection ProductsChemi-Pharm AS develops, produces and sells allergen-free disinfection agents, cleansing and skincare products and detergents. Learn more!
Name
Annemark OÜ
Registry code
11099964
VAT number
EE101241917
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
28.01.2005 (19)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
81221 - Other cleaning activities of buildings and industrial cleaning 46141 - Agents involved in the sale of machinery, industrial equipment, ships and aircraft 68201 - Rental and operating of own or leased real estate
261 611 €
66 516 €
25%
439 €
(estimate is approximate)
435 976 €
7
Submitted
No tax arrears
15%
15%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Meelis Liigsoo 30.10.1967 (56) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Projektijuht Aare OÜ 10613420 | - | - | - | Founder |
| 2019 06.07.2020 | 2020 09.06.2021 | 2021 26.05.2022 | 2022 31.05.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 146 335 € | 214 312 € | 227 977 € | 195 742 € | 261 611 € |
| Net profit (loss) for the period | 10 157 € | 46 263 € | 58 474 € | 66 744 € | 66 516 € |
| Profit Margin | 7% | 22% | 26% | 34% | 25% |
| Current Assets | 201 466 € | 191 993 € | 195 047 € | 277 856 € | 371 479 € |
| Fixed Assets | 57 848 € | 67 891 € | 121 774 € | 105 730 € | 82 133 € |
| Total Assets | 259 314 € | 259 884 € | 316 821 € | 383 586 € | 453 612 € |
| Current Liabilities | 59 135 € | 13 443 € | 11 306 € | 11 326 € | 17 636 € |
| Non Current Liabilities | 2 200 € | 2 200 € | 2 800 € | 2 800 € | 0 € |
| Total Liabilities | 61 335 € | 15 643 € | 14 106 € | 14 126 € | - |
| Share Capital | - | - | - | - | - |
| Equity | 197 979 € | 244 241 € | 302 715 € | 369 460 € | 435 976 € |
| Employees | 4 | 6 | 4 | 4 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 74 784.44 € | 14 882.76 € | 4 293.37 € | 8 |
| 2023 Q4 | 75 244.59 € | 13 728.06 € | 3 756.82 € | 8 |
| 2023 Q3 | 68 361.54 € | 12 288.04 € | 3 290.81 € | 7 |
| 2023 Q2 | 60 192.78 € | 9 175.93 € | 2 941.69 € | 7 |
| 2023 Q1 | 49 990.33 € | 8 806.99 € | 2 722.34 € | 7 |
| 2022 Q4 | 49 375.3 € | 8 651.2 € | 2 751.57 € | 6 |
| 2022 Q3 | 48 068.52 € | 7 578.85 € | 2 190.71 € | 5 |
| 2022 Q2 | 47 320.38 € | 7 732.94 € | 3 086.9 € | 4 |
| 2022 Q1 | 49 426.52 € | 10 325.76 € | 2 880.26 € | 5 |
| 2021 Q4 | 58 841.29 € | 10 632.51 € | 2 797.27 € | 4 |
| 2021 Q3 | 57 951.42 € | 10 417.51 € | 3 119.46 € | 3 |
| 2021 Q2 | 53 926.68 € | 10 909.37 € | 3 494.21 € | 4 |
| 2021 Q1 | 60 559.81 € | 9 990.48 € | 3 849.17 € | 6 |
| 2020 Q4 | 67 770.82 € | 10 247.44 € | 4 428.12 € | 7 |
| 2020 Q3 | 45 982.74 € | 9 454.1 € | 3 989.58 € | 9 |
| 2020 Q2 | 46 071.77 € | 8 348.26 € | 2 031.9 € | 6 |
| 2020 Q1 | 50 723.06 € | 4 706.97 € | 2 306.42 € | 5 |
